WO2014004761A2 - Plant parts and extracts having anticoccidial activity - Google Patents
Plant parts and extracts having anticoccidial activity Download PDFInfo
- Publication number
- WO2014004761A2 WO2014004761A2 PCT/US2013/048064 US2013048064W WO2014004761A2 WO 2014004761 A2 WO2014004761 A2 WO 2014004761A2 US 2013048064 W US2013048064 W US 2013048064W WO 2014004761 A2 WO2014004761 A2 WO 2014004761A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- infectoria
- extracts
- coccidiosis
- gallic acid
- eimeria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/49—Fagaceae (Beech family), e.g. oak or chestnut
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Definitions
- the present invention relates generally to the control of coccidiosis and, more specifically, to the application of plant parts, plant extracts and compounds to control coccidiosis in poultry and other animals.
- Coccidiosis is a major disease in the poultry industry and according to a recent survey, it is estimated that the global impact is greater than $3 billion USD annually
- Coccidiosis is caused by a protozoan parasite, namely Eimeria, belonging to the phylum Apicomplexa, and the family Eimieridae (Clare, R. A and Danforth, H. D (1989).
- Eimeria belonging to the phylum Apicomplexa
- Eimeriidae Ceretae
- the parasite invades the gut cells and causes necrosis in the intestine which leads to malabsorption, diarrhea, morbidity, reduction of weight gain, poor feed conversion, and, in severe cases, mortality (Williams, R.B (2005). Intercurrent coccidiosis and necrotic enteritis of chickens: Rational, integrated disease management by maintenance of gut integrity. Avian Pathology, 34(3), 159- 180). Seven different species of Eimeria, E. acervulina, E. brunetti, E. maxima, E. mitis, E. necatrix, E. praecox, and E. tenella are known to cause coccidiosis in poultry (Williams, 2005) and the species are highly host and site specific. E.
- tenella is one of the major species causing coccidiosis in poultry, and their site of infection is the caecum (Khazandi, M and Tivey, D (2010). Developing an in vitro method for Eimeria tenella attachment to its preferred and non-preferred intestinal sites. Experimental Parasitology, 125 (2), 137-140). Coccidiosis is currently controlled by medication, but the increasing emergence of drug-resistant strains of Eimeria requires the development of an alternative control strategy. Since plants are known to possess
- proanthocyanidins a condensed tannin rather than a hydrolysable tannin.
- Naidoo et al. teach an in vivo study using four plants selected based on their antioxidant activity (Naidoo et al. The value of plant extracts with antioxidant activity in attenuating coccidiosis in broiler chickens. Veterinary Parasitology. 153:214-219; 2008). They observed that one of the plants (Tulbaghia violacea) reduced the Eimeria oocyst counts in the chicken excreta and they speculate that this effect could be due to the antioxidant compound S (methylthiomethyl) cysteine sulfoxide.
- McDougald et al. describe the use of a muscadine pomace to enhance resistance to coccidiosis in broiler chickens (McDougald et al. Enhancement of Resistance to Coccidiosis and Necrotic Enteritis in Broiler Chickens by Dietary Muscadine Pomace. Avian Diseases. 52: 646-651 ; 2008).
- Muscadine pomace is a by-product of grapes used in wine production. They make no mention of efficacy of any specific compounds in the pomace.
- the proposed anti-coccidial activity differs significantly from the activities proposed by Wang et al. and Naidoo et al.
- the present invention consists of the identification and use of plant parts and plant extracts effective in the control of coccidiosis in animals, particularly in poultry.
- plant parts and natural extracts of Quercus injectoria, Rhus chinensis gall nut, Terminalia chebula fruit have been found to control coccidiosis in poultry and, more specifically, coccidiosis caused by Eimeria spp.
- the plant parts and natural extracts of gall nuts of Quercus infectoria, Rhus chinensis and fruits of Terminalia chebula result in a reduction of lesion score, oocysts per gram of fecal matter and mortality.
- the plant parts/extract was also found to have a direct inhibitory effect on the sporozoites of Eimeria, as observed in the in vitro MTT assay.
- Compounds selected gallic acid, gallo tannins and hydroly sable tannins were also found to reduce lesion score, oocysts per gram of fecal matter and mortality.
- the compounds were also found to have a direct inhibitory effect on the sporozoites of Eimeria, as observed in the in vitro MTT assay.
- the present invention also consists of a method of controlling coccidiosis in poultry and other animals by administering a composition comprising plant parts or extracts of plants containing an efficacious amount of gall nuts of Quercus infectoria, Rhus chinensis, Terminalia chebula fruit and/or compounds such as gallic acid, gallotannins and hydrolysable tannins.
- Fig. 1 is an image of caecal lesions of birds treated with Quercus infectoria
- Fig. 2 is a chart of the oocysts per gram (OPG) of excreta of birds treated with Quercus infectoria on day 7 post infection; columns with different superscripts are statistically significant (p ⁇ 0.05).
- OPG oocysts per gram
- Fig. 3 is microphotographic images of the H and E stained sections of caecum of birds treated with Quercus infectoria.
- Fig. 4 is a chart of the lesion score for E. acervulina, E. maxima and E. tenella for the birds treated with Q. infectoria water extract on day 5 post infection; columns with different superscripts are statistically significant (p ⁇ 0.05).
- Fig. 5 is a chart of the oocysts per gram (OPG) of excreta of birds treated with Q. infectoria water extract on day 7 post infection; columns with different superscripts are statistically significant (p ⁇ 0.05).
- OPG oocysts per gram
- Fig. 6 is a chart of the MTT assay carried out for the evaluation of Q. infectoria at various dosage levels along with a coccidiostat (Salinomycin) as positive control; columns with different superscripts are statistically significant (p ⁇ 0.05).
- Fig. 7 is a chart of PCR results after invasion of MDBK host cells with sporozoites and different concentrations of Q. infectoria.
- Fig. 8 is a chart of fold changes in Eimeria DNA for different time points versus T4 within one treatment.
- Fig. 9 is a chart of PCR results after invasion of MDBK host cells with sporozoites, pre-treated with different concentrations of Q. infectoria.
- Fig. 10 is a chart of fold changes in Eimeria DNA for different time points versus T20 within one treatment.
- Fig. 11 is a chart of the anti -sporozoite activity of the different fractions of Q. infectoria; columns with different superscripts are statistically significant (p ⁇ 0.05).
- Fig.12 is a High Performance Liquid Chromatogram (HPLC) chromatogram of water fraction of Q. infectoria.
- Fig.13 is a chart of the anti -sporozoite activity of the four major peaks of Q.
- Fig. 14 is the LC/MS/MS chromatogram of peak 1 of Q. infectoria.
- Fig. 15 is a chart depicting the correlation between the concentration of gallic acid and the anti -sporozoite activity of Q. infectoria; columns with different superscripts are statistically significant (p ⁇ 0.05).
- Fig. 16 is a chart of PCR results of MDBK host cells, pre-treated with 10 ppm gallic acid, invaded with sporozoites.
- Fig. 17 is a chart of fold changes in Eimeria DNA for different time points versus T20 within one treatment.
- Fig. 18 is a chart of PCR results after invasion of MDBK host cells with sporozoites, pre-treated with different concentrations of gallic acid.
- Fig. 19 is a chart of fold changes in Eimeria DNA for different time points versus T20 within one treatment.
- Fig. 20 is a chart of the lesion score on day 5 post infection of birds treated with gallic acid at different concentrations; columns with different superscripts are statistically significant (p ⁇ 0.05).
- Fig. 21 is a chart of the OPG on day 7 post infection of birds treated with gallic acid at different concentrations; columns with different superscripts are statistically significant (p ⁇ 0.05).
- Fig. 22 is a chart of the anti -sporozoite activity of Rhus chinensis and Terminalia chebula; columns with different superscripts are statistically significant (p ⁇ 0.05).
- Fig. 23 is a chart of PCR results after invasion of MDBK host cells with sporozoites, pre-treated with different concentrations of T. chebula.
- Fig. 24 is a chart of fold changes in Eimeria DNA for different time points versus T20 within one treatment.
- Fig. 25 is a chart of the lesion score on day 5 post infection of birds treated with R. chinensis and T. chebula; columns with different superscripts are statistically significant (p ⁇ 0.05).
- Fig. 21 is a chart of the OPG on day 7 post infection of birds treated with R. chinensis and T. chebula; columns with different superscripts are statistically significant (p ⁇ 0.05).
- a plant part, extract or compounds is termed to be efficacious if it can result in statistically significant reduction in the lesion score, the oocysts shed in the excreta, (Oocyst Per Gram (OPG)) or the mortality of the birds as compared to the infected control which is untreated.
- OPG Olecyst Per Gram
- administration of gallic acid and gallic acid containing formulations are described with formulations providing a dosage from 0.1 to 50ppm, preferably from 2 to 20ppm, and most preferably from 3 to lOppm through feed or water or an equivalent supplementation through other routes.
- the plants, plant parts and/or extracts described contain around a mininimum of 0.1 % of gallic acid.
- infectoria in controlling coccidiosis caused by other species of Eimeria alsoFurther, to determine the mode of action of Q. infectoria
- an in vitro method based on 3-(4, 5-Dimethyl-2-thiazolyl)-2,5- diphenyl-2H-tetrazolium bromide (MTT) reduction assay was developed to evaluate the anti- sporozoite activity of plant extracts as a measure of the viability of the sporozoites.
- MTT triphenyl-2H-tetrazolium bromide
- an in vitro assay was developed based on a co-culture of host cells and Eimeria parasites. Cells and parasite are combined in an assay with a positive control and different test products. The invasion and proliferation of the Eimeria parasites is measured by detecting Eimeria DNA using real-time PCR. For this, specific primers were selected and PCR conditions were optimised. The positive control and potential anticoccidial compounds are added to the in vitro assay in three different ways:
- the products are added to the sporozoites for a specific time, then removed and afterwards the sporozoites are added to the host cells.
- the products are added to the host cells for a specific time, then removed and afterwards the sporozoites are added to the host cells.
- Farm management Good farm managing practices were followed during the trial. The entire farm and the equipment used for the study were cleaned and disinfected before the arrival of the chicks. The birds were housed in cages organized on concrete flooring and a tray was provided at the bottom of the cages to facilitate collection of fecal samples. The temperature and humidity of the farm was monitored continuously.
- Vaccination schedule The birds were vaccinated for Newcastle Disease Virus (NDV) and Infectious Bursal Disease (IBD).
- NDV Newcastle Disease Virus
- IBD Infectious Bursal Disease
- Feed formulation A corn soya based mash diet was formulated. The feed ingredients were procured from Ponni feeds, Tamil Nadu, India. The mash feed was fed ad libitum to the birds throughout the study period. Three feed formulations were prepared according to the phases of the life of the bird; Prestarter (Day 1-10), Starter (Day 11-20), and Finisher feed (Day 21-42). No antimicrobials and supplements were used in the feed formulation.
- Control 1 (uninfected - T , calculator .
- Control 3 (Positive Control) .
- submit command 3 (Positive Control) .
- submit command 3 (Positive Control) .
- submit command 3 (Positive Control) .
- submit command 3 (Positive Control) .
- submit command 3 (Positive Control) .
- submit command 3 (Positive Control) .
- submit command 3 (Positive Control) .
- Coxistac is a product from Pfizer containing Salinomycin at 12 % concentration.
- OPG of excreta Triplicate samples of the excreta of the birds were collected randomly from the tray kept below the cages and the oocyst per gram was evaluated.
- + - denotes the severity of blood loss and amount of blood in the excreta.
- Lesion scoring of the caecum Lesion scoring of the caeca on day 5 and 7 post infection indicated that the lesions were severe on day 5 , and the birds started recovering on day 7 post infection which was indicated by the formation of a caecal plug. This followed the normal pattern of infection enabling the removal of oocysts from the caeca.
- the results of the lesion score showed that the positive control (Salinomycin control did not show any difference in the score as compared to the negative control due to inexplicable reasons.
- the treatment with Q. infectoria reduced the lesion score as compared to the negative control (Table 4). The reduced lesion score correlated with reduced excreta score and absence of mortality.
- OPG of excreta of the birds on day 7 post infection The counts of OPG of excreta of the birds on day 7 post infection are shown in Table 5. Unexpectedly, the anticoccidial Salinomycin treated birds (C3, Table 5) did not show any indication of reduction of oocysts as compared to the C2 (Table 5). The values presented are an average of three replicates.
- a 35 day in vivo challenge trial was conducted in broiler birds challenged with Eimeria tenella
- the treatment groups included, 1) control, uninfected normal birds; 2) negative control, birds infected with E. tenella and fed normal diet without any anticoccidial compounds; 3) positive control, birds infected and fed diet containing Coxistac (anticoccidial agent, Salinomycin) at the recommended dose of 500g/ton and 4) treatment group including infected birds administered diet containing Q. infectoria gall nut at 500g/ton dose. No mortality was observed in the positive control group and treatment group supplemented with crude powder of gall nuts of Quercus infectoria.
- the second in vivo experiment involved the following treatment groups.
- Coxistac is a product from Pfizer containing Salinomycin at 12 % concentration. Hence, addition of Coxistac at the mentioned dose of 500g/ton of feed will enable delivery of Salinomycin at 60 ppm levels in the feed which is the recommended preventive dose for broilers.
- Negative Cecum showed moderate load of different Eimerial stages (oocyst, schizont control C2 and merozoite) along with mild mucosal hemorrhages and mild to moderate mononuclear cell infiltration in mucosal, submucosal and muscular layers.
- Example 3 Efficacy of water extracts of Quercus infectoria in controlling mixed infection of coccidiosis
- Virulence of the oocysts obtained was evaluated in broiler birds and the dosage of the oocysts was finalized to be 5 X 10 5 based on the concentration that yields a lesion score of 3 and above for all the tested oocysts, E. tenella, E. maxima and E. acervulina.
- NDV Newcastle Disease Virus
- IBD Infectious Bursal Disease
- Extracts of gall nut of Q. infectoria were prepared by mixing the crude powder (100- 800 micron particle size) in distilled water at the ratio of 1 :2, then extracting at 80 to 90 ° C for one and half hour with agitation. The extract was filtered and again the residue was extracted in water in a similar manner. This was repeated for about 2 more times and the total liquid extract was freeze dried.
- Example 4 In vitro anti-sporozoite activity of 0. infectoria by MTT Assay
- an in vitro method based on 3-(4, 5-Dimethyl-2-thiazolyl)-2,5-diphenyl- 2H-tetrazolium bromide (MTT) reduction assay was developed to evaluate the anti- sporozoite activity of plant extracts as a measure of the viability of the sporozoites.
- the optimized method included the preparation, sterilization and purification of sporozoites, followed by incubation of sporozoite suspension (minimum of 10 5 cells/ml) with required concentration of plant extract.
- the plant samples were prepared by mixing crude powder into a known volume of distilled water to achieve the specific ppm, vortexed for 2 min and filtered through a 0.2 ⁇ syringe filter.
- MTT-PMS solution (0.2 millimolar each) is incubated with the sporozoite suspension (at 1 : 10 ratio) for 2 h at 41 °C. After incubation, the contents are centrifuged at 800 g for 5 min and the supernatant is carefully removed. The purple dye formazan is dissolved in 200 ul DMSO and the absorbance is measured at 530 nm against a reference wavelength of 630 nm.
- MTT assay was carried out for the evaluation of Q. infectoria at various dosage levels along with Coccidiostac (Salinomycin) as positive control (Fig. 6). There was a dose dependent reduction in the viability of sporozoites in the Q. infectoria treated samples as compared to the control.
- Example 5 In vitro effect of Q. infectoria on Eimeria tenella sporozoite invasion and proliferation in host cells
- Sporozoites were obtained from sporulated oocysts after glass bead grinding and enzymatic excystation.
- As host cells Madin-Darby Bovine Kidney (MDBK) cells, were selected. Sporozoites and Quercus infectoria at 50 and 100 ppm were added to MDBK host cells for four hours. Afterwards, the medium was removed, cells were washed and fresh medium was added. After 4 (T4), 24 (T24), 48 (T48) and 72 (T72) hours the medium and MDBK cells were collected and stored at -20 °C.
- MDBK Madin-Darby Bovine Kidney
- the negative control was MDBK cells infected with Eimeria sporozoites, incubated in cell culture medium.
- the positive control was MDBK cells infected with Eimeria sporozoites, incubated with a 5 ⁇ g/ml solution of Salinomycin.
- the negative control shows a clear Eimeria proliferation since there is a 15 fold increase in Eimeria DNA at 72 hours versus the start at 4 hours.
- the positive control was able to inhibit the proliferation completely.
- Q. infectoria treatments a clear inhibition of the proliferation was observed versus the start of 4 hours, in a dose dependent manner.
- Example 6 In vitro effect of Q. infectoria on Eimeria tenella sporozoite invasion and proliferation in host cells. [00082] An experiment was conducted to evaluate the in vitro effect of Q. infectoria on Eimeria tenella sporozoite invasion and proliferation in host cells.
- Sporozoites were obtained from sporulated oocysts after glass bead grinding and enzymatic excystation.
- As host cells Madin-Darby Bovine Kidney (MDBK) cells, were selected. Sporozoites were pre-treated with 50, 100 and 250 ppm of Quercus infectoria for three hours. Thereafter, the sporozoite suspension was washed and put onto a culture of MDBK cells for 20 hours. After incubation, the medium was removed, cells were washed and fresh medium was added. After 20, 72 and 96 hours the medium and MDBK cells were collected and stored at -20 °C.
- MDBK Madin-Darby Bovine Kidney
- the negative control was MDBK cells infected with Eimeria sporozoites, incubated in cell culture medium.
- the positive control was MDBK cells infected with Eimeria sporozoites, incubated with a 5 ⁇ g/ml solution of Salinomycin.
- the negative control shows a clear Eimeria proliferation since there is a 20 fold increase in Eimeria DNA at 96 hours versus the start at 20 hours.
- the positive control was able to inhibit the proliferation completely.
- the different dosages of Q. infectoria all inhibited the Eimeria proliferation.
- Bioassay Guided Fractionation assay (BGFA) of Q. infectoria gall nuts was carried out using the modified MTT reduction assay as the bioassay as we had identified that the crude extract possess anti-sporozoite activity and this could be one of the mode of action by which it is able to control coccidiosis.
- Q. infectoria gall nut crude powder was fractionated using different solvent by column chromatography. The sample from each of the fractions was evaluated for their anti-sporozoite activity. Methanol and water fractions of Q. infectoria showed better reduction in the viability of sporozoites as compared to the other fractions and were comparable to the Salinomycin control (Fig 11).
- Phytochemical analyses of the active fractions were carried out by High Performance Liquid Chromatography (HPLC) to identify the active ingredient/s responsible for the anti-sporozoite activity.
- HPLC High Performance Liquid Chromatography
- Four major peaks were observed in the HPLC chromatogram of both methanol and water fractions, with one peak corresponding to the retention time of a gallic acid standard (Fig. 12).
- Q. infectoria gall nut are known to possess 60 to 70 % hydrolysable tannins which can hydrolyse to release gallic acid in addition to about 7 % free gallic acid present in it.
- Sporozoites were obtained from sporulated oocysts after glass bead grinding and enzymatic excystation.
- As host cells Madin-Darby Bovine Kidney (MDBK) cells, were selected. MDBK cells were incubated with 10 ppm gallic acid for seven hours. Afterwards the medium was removed and a sporozoite suspension was added to the MDBK cells for 20 hours. After incubation, the medium was removed, cells were washed and fresh medium was added. After 20, 72 and 96 hours the medium and the MDBK cells were collected and stored at -20 °C.
- MDBK Madin-Darby Bovine Kidney
- the negative control was MDBK cells infected with Eimeria sporozoites, incubated in cell culture medium.
- the positive control was MDBK cells infected with Eimeria sporozoites, incubated with a 5 ⁇ g/ml solution of Salinomycin.
- the negative control shows a clear Eimeria proliferation since there is a 60 fold increase in Eimeria DNA at 96 hours versus the start at 20 hours.
- the positive control was able to inhibit the proliferation almost completely.
- gallic acid treatment a clear inhibition of the proliferation was observed in a dose dependent manner. This indicates that gallic acid at a low dose of 10 ppm is able to protect the host cells to some extend against Eimeria proliferation.
- Example 9 In vitro effect of gallic acid on Eimeria tenella sporozoite invasion and proliferation in host cells
- Sporozoites were obtained from sporulated oocysts after glass bead grinding and enzymatic excystation.
- As host cells Madin-Darby Bovine Kidney (MDBK) cells, were selected. Sporozoites were pre-treated with 10, 25 and 50 ppm gallic acid monohydrate for three hours. Thereafter, the sporozoite suspension was washed and put onto a culture of MDBK cells for 20 hours. After incubation, the medium was removed, cells were washed and fresh medium was added. After 20, 72 and 96 hours the medium and MDBK cells were collected and stored at -20 °C.
- MDBK Madin-Darby Bovine Kidney
- the negative control was MDBK cells infected with Eimeria sporozoites, incubated in cell culture medium.
- the positive control was MDBK cells infected with Eimeria sporozoites, incubated with a 5 ⁇ g/ml solution of Salinomycin.
- the negative control shows a clear Eimeria proliferation since there is a 20 fold increase in Eimeria DNA at 96 hours versus the start at 20 hours.
- the positive control as well as the different dosages of gallic acid inhibited the Eimeria proliferation. There was a slightly lower effect visible for 10 ppm gallic acid. But this is negligible in comparison to the increase in the negative control.
- Rhus chinensis Choinese gall nut
- Terminalia chebula Indian gall nut
- Rhus chinensis contains about 70 % hydrolysable tannins
- Terminalia chebula contains around 0. 28% free gallic acid.
- T. chebula contains 25 to 40% hydrolysable tannins which can degrade to release gallic acid.
- Example 12 In vitro effect of plants containing gallic acid on Eimeria tenella sporozoite invasion and proliferation in host cells
- Sporozoites were obtained from sporulated oocysts after glass bead grinding and enzymatic excystation.
- As host cells Madin-Darby Bovine Kidney (MDBK) cells, were selected. Sporozoites were pre-treated with 50, 100 and 250 ppm of Terminalia chebula for three hours. Thereafter, the sporozoite suspension was washed and put onto a culture of MDBK cells for 20 hours. After incubation, the medium was removed, cells were washed and fresh medium was added. After 20, 72 and 96 hours the medium and MDBK cells were collected and stored at -20 °C.
- MDBK Madin-Darby Bovine Kidney
- the negative control was MDBK cells infected with Eimeria sporozoites, incubated in cell culture medium.
- the positive control was MDBK cells infected with Eimeria sporozoites, incubated with a 5 ⁇ g/ml solution of Salinomycin.
- the negative control shows a clear Eimeria proliferation since there is a 20 fold increase in Eimeria DNA at 96 hours versus the start at 20 hours.
- the positive control as well as 250 ppm T. chebula completely inhibited the Eimeria proliferation. There was a dose- response effect visible although the lower effect for 100 ppm T. chebula is negligible in comparison to the increase in the negative control
- Example 13 Efficacy of plants containing gallic acid in controlling coccidiosis
- Rhus chinensis at 200 and 500 ppm and Terminalia chebula at 1000 ppm were able to reduce the score for all the three tested species of Eimeria as compared to the infected control and even the positive control, Salinomycin (Fig. 25).
- the oocysts per gram showed a similar trend (Fig. 26), however, mortality was not observed in any of the treatment groups including the infected control. Dose dependent response was observed with Rhus chinensis.
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BR112014032632A BR112014032632A2 (en) | 2012-06-27 | 2013-06-27 | compositions and method for controlling coccidiosis in animals, and method for reducing sporozoite activity in an animal. |
| KR1020157002227A KR102104921B1 (en) | 2012-06-27 | 2013-06-27 | Plant parts and extracts having anticoccidial activity |
| JP2015520483A JP6441794B2 (en) | 2012-06-27 | 2013-06-27 | Plant parts and extracts having anti-coccidial activity |
| AU2013280331A AU2013280331C1 (en) | 2012-06-27 | 2013-06-27 | Plant parts and extracts having anticoccidial activity |
| EP13808799.4A EP2866794A4 (en) | 2012-06-27 | 2013-06-27 | PARTS AND PLANT EXTRACTS WITH ANTICOCCIDIAN ACTIVITY |
| CN201380044551.1A CN104936583A (en) | 2012-06-27 | 2013-06-27 | Plant parts and extracts having anticoccidial activity |
| CA2877884A CA2877884C (en) | 2012-06-27 | 2013-06-27 | Animal feed compositions for controlling coccidiosis in animals |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261664795P | 2012-06-27 | 2012-06-27 | |
| US61/664,795 | 2012-06-27 | ||
| IN177DE2013 | 2013-01-23 | ||
| IN177/DEL/2013 | 2013-01-23 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2014004761A2 true WO2014004761A2 (en) | 2014-01-03 |
| WO2014004761A3 WO2014004761A3 (en) | 2014-02-20 |
Family
ID=49784015
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2013/048064 Ceased WO2014004761A2 (en) | 2012-06-27 | 2013-06-27 | Plant parts and extracts having anticoccidial activity |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20140161919A1 (en) |
| EP (1) | EP2866794A4 (en) |
| JP (1) | JP6441794B2 (en) |
| KR (1) | KR102104921B1 (en) |
| CN (1) | CN104936583A (en) |
| AU (1) | AU2013280331C1 (en) |
| BR (1) | BR112014032632A2 (en) |
| CA (1) | CA2877884C (en) |
| WO (1) | WO2014004761A2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3539549A1 (en) | 2018-03-12 | 2019-09-18 | Adisseo France S.A.S. | Food additive made of saponins for the treatment of coccidiosis |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017066777A1 (en) * | 2015-10-15 | 2017-04-20 | Kemin Industries, Inc. | Compositions and methods of improving performance and intestinal health of poultry |
| CN106107194A (en) * | 2016-06-28 | 2016-11-16 | 北京中农华正兽药有限责任公司 | Purify compositions and the using method of small intestine of broiler chickens coccidiosis |
| KR102408566B1 (en) * | 2020-04-09 | 2022-06-16 | 대한민국 | Composition for Improving Skin Wrinkles Using an Extract of Terminalia bialata |
| KR102660905B1 (en) * | 2020-09-25 | 2024-04-24 | 씨제이제일제당 (주) | Anti-coccidial composition comprising violacein and uses thereof |
| KR102755997B1 (en) * | 2020-09-25 | 2025-01-15 | 씨제이제일제당 (주) | Anti-coccidial composition comprising mangosteen and uses thereof |
| CN120977432A (en) * | 2025-07-23 | 2025-11-18 | 中国科学院动物研究所 | A screening method for small molecule compounds that inhibit insect-borne diseases and their related applications. |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0395294A3 (en) | 1989-04-25 | 1991-05-22 | Takeda Chemical Industries, Ltd. | Control of protozoal disease |
| CH688172A5 (en) * | 1994-10-26 | 1997-06-13 | Crina | additive composition as food for poultry. |
| BR0110382A (en) * | 2000-04-27 | 2003-06-24 | Pfizer Prod Inc | Use of azalide antibiotic compositions for the treatment or prevention of a bacterial or protozoal infection in mammals |
| US6908620B2 (en) * | 2002-12-09 | 2005-06-21 | University Of Georgia Research Foundation, Inc. | Coccidial vaccine and methods of making and using same |
| DE102006038292A1 (en) | 2006-08-16 | 2008-02-21 | Bayer Healthcare Ag | Transdermal use of triazines to combat coccidial infections |
| DE102007045724B4 (en) * | 2007-09-24 | 2012-01-26 | Evonik Stockhausen Gmbh | Superabsorbent composition with tannins for odor control, process for their preparation and use |
| CN101744839A (en) * | 2008-12-08 | 2010-06-23 | 杨建华 | Application of Uygur medicine of nutgall and extract thereof with functions of inhibiting cutaneous pigmentation, screening sun and whitening |
| CN102988764B (en) * | 2012-12-19 | 2014-07-23 | 西安市昌盛动物保健品有限公司 | Chinese medicinal preparation for resisting coccidiosis and preparation method thereof |
-
2013
- 2013-06-27 BR BR112014032632A patent/BR112014032632A2/en not_active Application Discontinuation
- 2013-06-27 JP JP2015520483A patent/JP6441794B2/en active Active
- 2013-06-27 WO PCT/US2013/048064 patent/WO2014004761A2/en not_active Ceased
- 2013-06-27 EP EP13808799.4A patent/EP2866794A4/en not_active Withdrawn
- 2013-06-27 US US13/928,504 patent/US20140161919A1/en not_active Abandoned
- 2013-06-27 AU AU2013280331A patent/AU2013280331C1/en active Active
- 2013-06-27 KR KR1020157002227A patent/KR102104921B1/en active Active
- 2013-06-27 CA CA2877884A patent/CA2877884C/en active Active
- 2013-06-27 CN CN201380044551.1A patent/CN104936583A/en active Pending
-
2015
- 2015-07-17 US US14/802,545 patent/US10426808B2/en active Active
Non-Patent Citations (5)
| Title |
|---|
| CLARE, R. A; DANFORTH, H. D: "Major histocompatibility complex control of immunity elicited by genetically engineered Eimeria tenella (Apicomplexa) antigen in chickens", INFECTION AND IMMUNITY, vol. 57, no. 3, 1989, pages 701 - 705 |
| KHAZANDI, M; TIVEY, D: "Developing an in vitro method for Eimeria tenella attachment to its preferred and non-preferred intestinal sites", EXPERIMENTAL PARASITOLOGY, vol. 125, no. 2, 2010, pages 137 - 140, XP027015493 |
| See also references of EP2866794A4 |
| TIPU, M.A.; AKHTAR, M.S.; ANJUM, M.I; RAJA, M. L: "New dimension of medicinal plants as animal feed", PAKISTAN VET. J., vol. 26, no. 3, 2006, pages 144 - 148, XP055498333 |
| WILLIAMS, R.B.: "Intercurrent coccidiosis and necrotic enteritis of chickens: Rational, integrated disease management by maintenance of gut integrity", AVIAN PATHOLOGY, vol. 34, no. 3, 2005, pages 159 - 180 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3539549A1 (en) | 2018-03-12 | 2019-09-18 | Adisseo France S.A.S. | Food additive made of saponins for the treatment of coccidiosis |
Also Published As
| Publication number | Publication date |
|---|---|
| KR102104921B1 (en) | 2020-04-28 |
| JP2015522023A (en) | 2015-08-03 |
| KR20150023899A (en) | 2015-03-05 |
| AU2013280331B2 (en) | 2017-12-14 |
| CN104936583A (en) | 2015-09-23 |
| AU2013280331A1 (en) | 2015-01-22 |
| WO2014004761A3 (en) | 2014-02-20 |
| EP2866794A2 (en) | 2015-05-06 |
| BR112014032632A2 (en) | 2017-06-27 |
| CA2877884C (en) | 2022-09-06 |
| JP6441794B2 (en) | 2018-12-19 |
| US20140161919A1 (en) | 2014-06-12 |
| US20160015765A1 (en) | 2016-01-21 |
| CA2877884A1 (en) | 2014-01-03 |
| EP2866794A4 (en) | 2015-12-09 |
| AU2013280331C1 (en) | 2018-06-21 |
| US10426808B2 (en) | 2019-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10426808B2 (en) | Plant extracts having anticoccidial activity | |
| Ahmad et al. | Management and control of coccidiosis in poultry—A review | |
| Abbas et al. | In vivo anticoccidial effects of Beta vulgaris (sugar beet) in broiler chickens | |
| Imran et al. | Anticoccidial Efficacy of Citrus sinensis Essential Oil in Broiler Chicken. | |
| JP5101081B2 (en) | Feed for prevention and / or treatment of coccidiosis and clostridiasis | |
| Cejas et al. | Evaluation of quebracho red wood (Schinopsis lorentzii) polyphenolic vegetable extract for the reduction of coccidiosis in broiler chicks | |
| Wang et al. | Anticoccidial effects of areca nut (Areca catechu L.) extract on broiler chicks experimentally infected with Eimeria tenella | |
| US20130079402A1 (en) | Use of at Least One Dialkyl Thiosulfonate or Thiosulfinate for Reducing the Number of Apicomplexa in an Animal | |
| Acharya et al. | Alternatives to fight against coccidiosis: A review | |
| Dhayanithi et al. | Immune protection by Rhizophora apiculata in clownfish against Vibrio alginolyticus | |
| Youssef et al. | Comparative Effects of Dietary Saponin and Probiotic Supplementation on Performance, Carcass Traits and Intestinal Histomorphology of Broilers Challenged with Eimeria tenella. | |
| Adamu et al. | Effect of Lepidium sativum L.(garden cress) seed and its extract on experimental Eimeria tenella infection in broiler chickens | |
| US10568923B2 (en) | Plant parts and extracts having anticoccidial activity | |
| Yang et al. | Functional and mechanistic studies of two anti-coccidial herbs, Bidens pilosa and Artemisia indica | |
| US20240299324A1 (en) | Anticoccidial composition comprising coumaric acid and use thereof | |
| Zyan et al. | Molecular identification of Eimeria tenella in broiler chickens in Kalyoubia governorate and evaluation of different strategies for control cecal coccidiosis. | |
| Fayyaz et al. | Anticoccidial Effects of Trachyspermum ammi Essential Oil Against Caecal Coccidiosis in Broiler Chickens | |
| KR100836944B1 (en) | Composition for the prevention or treatment of coccidiosis, including dodol | |
| Airaodion et al. | Antiplasmodial potential of mango (Mangifera indica) stem bark against plasmodium berghei in infected Swiss albino mice | |
| Guven et al. | Anticoccidal efficacy of usnic acid in broilers | |
| Sajid | Ameliorative effect of poly-herbal mixture on Caecal coccidiosis in broiler chicks | |
| JP7574430B2 (en) | Anticoccidial composition containing mangosteen and its use | |
| ALLAM ABD EL–DAYEM et al. | THE POTENTIAL EFFICACY OF ALOE VERA GEL AND YUCCA SCHIDIGERAEXTRACT ON GROWTH PERFORMANCE, INTESTINAL LESIONS AND INFLAMMATORY RESPONSE IN BROILER CHICKENS CHALLENGED WITH COCCIDIA | |
| Otu et al. | Oocysts Output of Broilers Experimentally Infected with Eimeria tenella And Treated with N-Butanol Leaf Extract of Khaya senegalensis | |
| Debnath | Physiological and Nutritional Effects of Dietary Zanthoxylum acanthopodium Seed Supplementation on Growth Performance, Immune Response and Disease Resistance in Neolissochilu shexagonolepis (McClelland 1839) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13808799 Country of ref document: EP Kind code of ref document: A2 |
|
| DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
| ENP | Entry into the national phase |
Ref document number: 2877884 Country of ref document: CA |
|
| ENP | Entry into the national phase |
Ref document number: 2015520483 Country of ref document: JP Kind code of ref document: A |
|
| ENP | Entry into the national phase |
Ref document number: 2013280331 Country of ref document: AU Date of ref document: 20130627 Kind code of ref document: A |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2013808799 Country of ref document: EP |
|
| ENP | Entry into the national phase |
Ref document number: 20157002227 Country of ref document: KR Kind code of ref document: A |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13808799 Country of ref document: EP Kind code of ref document: A2 |
|
| REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112014032632 Country of ref document: BR |
|
| ENP | Entry into the national phase |
Ref document number: 112014032632 Country of ref document: BR Kind code of ref document: A2 Effective date: 20141226 |

